
Apyx Medical Corporation: shareholders and insiders
Price
$2.81
November 13, 2026Market cap $118M
What Ploutos Investor adds for Apyx Medical
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
Insiders and their shares
Purchases and sales by officers and directors from Nov 16, 2025 to Jul 2, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
–
nobody
From Nov 16, 2025 to Nov 16, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
No sales in the period.
- Jun 30, 2026Lawrence WaldmanDirectorKind
- Jun 30, 2026Lawrence WaldmanDirectorKind
- Jun 15, 2026Shawn David RomanChief Operating OfficerKind
- Jun 15, 2026Shawn David RomanChief Operating OfficerKind
- Jun 11, 2026Stavros G. VizirgianakisDirectorKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Lawrence WaldmanDirector | 12.0K | $1.88 | $22.6K | Form 4 | |
| Jun 30, 2026 | Lawrence WaldmanDirector | 5,024 | $4.49 | $22.6K | Form 4 | |
| Jun 15, 2026 | Shawn David RomanChief Operating Officer | 15.0K | $3.23 | $48.5K | Form 4 | |
| Jun 15, 2026 | Shawn David RomanChief Operating Officer | 10.5K | $4.60 | $48.5K | Form 4 | |
| Jun 11, 2026 | Stavros G. VizirgianakisDirector | 450.0K | – | – | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade.
Insiders and their shares
Every buy and sale by APYX's officers and directors from 2005 up to November 15, 2025, 21 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 16 more, back to 2005
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Nantahala Capital Management, LLCwith 2 more personsShare of class9.99%
- Royce & AssociatesShare of class7.81%
- Philotimo Fund, LPwith 3 more personsShare of class5.40%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLCwith 2 more persons | 9.99% | 4.11M | Feb 13, 20262 filings since Feb 14, 2025 | 13G/A | |
| Royce & Associates | 7.81% | 3.27M | Jul 21, 20262 filings since Jan 20, 2026 | 13G/A | |
| Philotimo Fund, LPwith 3 more persons | 5.40% | 2.28M | Oct 28, 2026 | 13G |
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Point72 (Cohen)In the quarter-24%
- Citadel Advisors (Griffin)In the quarter+56%
- Millennium Mgmt (Englander)In the quarter-7.4%
- Renaissance TechnologiesIn the quarter-31%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Point72 (Cohen) | 26.4K | -24% | $100.0K | 0.00% |
| Citadel Advisors (Griffin) | 168.3K | +56% | $800.0K | 0.00% |
| Millennium Mgmt (Englander) | 242.7K | -7.4% | $1.1M | 0.00% |
| Renaissance Technologies | 383.4K | -31% | $900.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 0.51% of its shares outstanding were held short, +3.3% since the report before.
- Shares held short
- 213.7K
- 0.51%
- Since the report before206.8K on Sep 30, 2026
- +3.3%
- 1.8
- 118.9K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 22%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 2.22M
- Nov 15, 2023: Shares held short 2.02M
- Nov 30, 2023: Shares held short 1.60M
- Dec 15, 2023: Shares held short 1.62M
- Dec 29, 2023: Shares held short 1.59M
- Jan 12, 2024: Shares held short 1.56M
- Jan 31, 2024: Shares held short 1.51M
- Feb 15, 2024: Shares held short 1.57M
- Feb 29, 2024: Shares held short 1.59M
- Mar 15, 2024: Shares held short 1.57M
- Mar 28, 2024: Shares held short 706.7K
- Apr 15, 2024: Shares held short 371.1K
- Apr 30, 2024: Shares held short 540.3K
- May 15, 2024: Shares held short 412.6K
- May 31, 2024: Shares held short 327.5K
- Jun 14, 2024: Shares held short 298.9K
- Jun 28, 2024: Shares held short 291.5K
- Jul 15, 2024: Shares held short 280.6K
- Jul 31, 2024: Shares held short 285.6K
- Aug 15, 2024: Shares held short 296.9K
- Aug 30, 2024: Shares held short 265.1K
- Sep 13, 2024: Shares held short 243.9K
- Sep 30, 2024: Shares held short 236.1K
- Oct 15, 2024: Shares held short 234.9K
- Oct 31, 2024: Shares held short 230.2K
- Nov 15, 2024: Shares held short 140.5K
- Nov 29, 2024: Shares held short 120.0K
- Dec 13, 2024: Shares held short 124.2K
- Dec 31, 2024: Shares held short 126.4K
- Jan 15, 2025: Shares held short 148.6K
- Jan 31, 2025: Shares held short 149.2K
- Feb 14, 2025: Shares held short 141.9K
- Feb 28, 2025: Shares held short 139.0K
- Mar 14, 2025: Shares held short 125.3K
- Mar 31, 2025: Shares held short 144.6K
- Apr 15, 2025: Shares held short 247.3K
- Apr 30, 2025: Shares held short 258.8K
- May 15, 2025: Shares held short 413.6K
- May 30, 2025: Shares held short 299.3K
- Jun 13, 2025: Shares held short 212.9K
- Jun 30, 2025: Shares held short 207.3K
- Jul 15, 2025: Shares held short 299.2K
- Jul 31, 2025: Shares held short 319.5K
- Aug 15, 2025: Shares held short 313.2K
- Aug 29, 2025: Shares held short 231.9K
- Sep 15, 2025: Shares held short 235.4K
- Sep 30, 2025: Shares held short 260.2K
- Oct 15, 2025: Shares held short 312.7K
- Oct 31, 2025: Shares held short 362.6K
- Nov 14, 2025: Shares held short 279.7K
- Nov 28, 2025: Shares held short 113.9K
- Dec 15, 2025: Shares held short 109.3K
- Dec 31, 2025: Shares held short 111.7K
- Jan 15, 2026: Shares held short 111.9K
- Jan 30, 2026: Shares held short 127.0K
- Feb 13, 2026: Shares held short 142.0K
- Feb 27, 2026: Shares held short 173.6K
- Mar 13, 2026: Shares held short 164.9K
- Mar 31, 2026: Shares held short 192.8K
- Apr 15, 2026: Shares held short 195.8K
- Apr 30, 2026: Shares held short 221.2K
- May 15, 2026: Shares held short 167.4K
- May 29, 2026: Shares held short 211.9K
- Jun 15, 2026: Shares held short 139.7K
- Jun 30, 2026: Shares held short 177.3K
- Jul 15, 2026: Shares held short 251.7K
- Jul 31, 2026: Shares held short 267.1K
- Aug 14, 2026: Shares held short 230.4K
- Aug 31, 2026: Shares held short 205.2K
- Sep 15, 2026: Shares held short 218.0K
- Sep 30, 2026: Shares held short 206.8K
- Oct 15, 2026: Shares held short 213.7K
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading35.4% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 35.4% of the shares in the reported trades were short sales, against 23.5% in the 14 before.
- Last 14 sessionsOct 27, 2026 – Nov 13, 2026
- 35.4%
- The 14 beforeOct 7, 2026 – Oct 26, 2026
- 23.5%
- Change
- +11.9 pts
- Short sales a dayon average, of 53.2K shares
- 18.8K
- More than atof 3,649 US-listed companies, same days
- 11%
- Median of alleight in ten from 34.6% to 63.4%
- 50.1%
- Short sales
- Oct 7, 2026: Short sales 35.9%
- Oct 8, 2026: Short sales 40.2%
- Oct 9, 2026: Short sales 21%
- Oct 12, 2026: Short sales 13.2%
- Oct 13, 2026: Short sales 26.7%
- Oct 14, 2026: Short sales 17.3%
- Oct 15, 2026: Short sales 10.4%
- Oct 16, 2026: Short sales 33.4%
- Oct 19, 2026: Short sales 35.5%
- Oct 20, 2026: Short sales 6.6%
- Oct 21, 2026: Short sales 46.9%
- Oct 22, 2026: Short sales 38%
- Oct 23, 2026: Short sales 31.3%
- Oct 26, 2026: Short sales 26.6%
- Oct 27, 2026: Short sales 19.7%
- Oct 28, 2026: Short sales 64.8%
- Oct 29, 2026: Short sales 36.8%
- Oct 30, 2026: Short sales 28.6%
- Nov 2, 2026: Short sales 42.7%
- Nov 3, 2026: Short sales 60%
- Nov 4, 2026: Short sales 59.3%
- Nov 5, 2026: Short sales 26.6%
- Nov 6, 2026: Short sales 33%
- Nov 9, 2026: Short sales 50.6%
- Nov 10, 2026: Short sales 26.9%
- Nov 11, 2026: Short sales 34.3%
- Nov 12, 2026: Short sales 38.7%
- Nov 13, 2026: Short sales 13.5%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Lawrence WaldmanDirectorDirectly49.9K
- Shawn David RomanChief Operating OfficerDirectly16.5K
- Matthew C HillChief Financial OfficerDirectly8,500
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Lawrence WaldmanDirector | 49.9K | – | Jun 30, 2026 | Form 4 |
| Shawn David RomanChief Operating Officer | 16.5K | – | Jun 15, 2026 | Form 4 |
| Matthew C HillChief Financial Officer | 8,500 | – | Aug 13, 2024 | Form 4 |
A lower bound: it counts only the 3 officers and directors with a market trade since Nov 17, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
2 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 47
- Q4 2025: Managers 59
- Q1 2026: Managers 67
- Q2 2026: Managers 68
Institutional investors by quarter
The fund managers holding APYX, quarter by quarter, from Q4 2018 to Q2 2025, 27 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 68 managers held 24.65M shares, worth $111M. During the quarter 11 opened a position, 10 closed one, 23 added and 21 trimmed.
The largest holders, Q2 2026
- Nantahala Capital ManagementIn the quarter+90%
- Royce & AssociatesIn the quarter+25%
- Archon Capital ManagementIn the quarter-5.2%
- Vanguard Capital ManagementIn the quarter-1.3%
- Essex Investment ManagementIn the quarter+26%
- AIGH Capital ManagementIn the quarter+2.1%
- Silverberg Bernstein Capital ManagementIn the quarter-0.1%
- Commonwealth Equity ServicesIn the quarter
- Horizon Kinetics Asset ManagementIn the quarter-4.9%
- BlackRockIn the quarter+6.3%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Nantahala Capital Management | 6.54M | +90% | $29M |
| Royce & Associates | 3.27M | +25% | $15M |
| Archon Capital Management | 2.64M | -5.2% | $12M |
| Vanguard Capital Management | 1.53M | -1.3% | $6.9M |
| Essex Investment Management | 1.14M | +26% | $5.1M |
| AIGH Capital Management | 1.13M | +2.1% | $5.1M |
| Silverberg Bernstein Capital Management | 1.04M | -0.1% | $4.7M |
| Commonwealth Equity Services | 649.1K | $2.9M | |
| Horizon Kinetics Asset Management | 585.0K | -4.9% | $2.6M |
| BlackRock | 561.0K | +6.3% | $2.5M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Apyx Medical's filings show?
Who buys and sells is one part of Apyx Medical's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have APYX's insiders bought or sold?
From Jun 15, 2026 to Jul 2, 2026 Apyx Medical's insiders reported no purchase or sale of shares on the market.
Which well-known managers hold APYX?
4 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $1.1M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.